Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Name (Synonyms) | Correlation |
---|
Navigate: Correlations HPO
There is one clinical trial.
The present overall project evaluates an intervention carried out by the Swedish state-owned gambling operator AB Svenska Spel, in order to help high-risk gamblers reduce or quit their gambling. The intervention is a motivational telephone intervention, called by responsible gambling officers trained in motivational interviewing, and who call gamblers who are screened for suspected high-risk gambling practices either through the operator's own records, or because they have voluntarily taken a self-test indicating a hazardous gambling pattern. The present projects evaluates the effectiveness, user satisfaction and acceptability of the intervention, in two parts: 1) A retrospective, register-based follow-up of gamblers reached by the telephone intervention, in comparison to control individuals for whom attempts were made to carry out the same intervention, but who were never successfully reached on telephone. The effectiveness measures include potential changes in gambling level (frequency, level of wagering) post-intervention compared to pre-intervention, as well as occurrence of deposit limits, or voluntary self-exclusion. 2) A prospective web survey study involving individuals reached with the intervention from November, 2020, who - after receiving electronic written information and after providing informed consent - will answer a web survey around 10 days after the intervention, about their attitudes to the telephone intervention, and their self-reported gambling (on the same operator and on other gambling operators), self-limiting interventions and treatment seeking after the intervention. The study will provide important data on the effectiveness of this intervention aiming to reduce high-risk gambling practices, and will be able to study also the risk of gamblers transferring their gambling practices to other operators after a motivational intervention as the present one. Also, as acceptability and user satisfaction of the intervention are crucial for its success over time, these measures are also included in order to improve the understanding or how effective responsible gambling interventions can be implemented by gambling operators with a harm-reducing mission.
Description: Change in wagering (any, and frequency) for each of the specific gambling types, during four weeks after the intervention, compared to the eight weeks prior to the intervention.
Measure: Change in gambling frequency. Time: 4 weeksDescription: Change in wagering (amounts) for each of the specific gambling types, during four weeks after the intervention, compared to the eight weeks prior to the intervention.
Measure: Change in money wagered Time: 4 weeksDescription: Change in losses for each of the specific gambling types, during four weeks after the intervention, compared to the eight weeks prior to the intervention.
Measure: Change in money lost Time: 4 weeksDescription: Occurrence of deposit limits and voluntary self-exclusions post-intervention,during four weeks after the intervention, compared to the eight weeks prior to the intervention.
Measure: Occurrence of any self-limiting intervention post-intervention Time: 4 weeksDescription: Reduced wagering frequency for each of the specific gambling types, during the approximate 10-day period after the intervention, in gamblers reached with the intervention in the prospective study part (self-reported in survey sent on first business day 10 days after the intervention)
Measure: Change in wagering frequency in both the own operator and other operators Time: 10 daysDescription: Reduced wagering (amounts) and losses for each of the specific gambling types, during the approximate 10-day period after the intervention, in gamblers reached with the intervention in the prospective study part (self-report in survey sent on first business day 10 days after the intervention)
Measure: Change in wagering amounts in both the own operator and other operators Time: 10 daysDescription: Gambling losses (amounts) for each of the specific gambling types, during the approximate 10-day period after the intervention, in gamblers reached with the intervention in the prospective study part (survey sent on first business day 10 days after the intervention)
Measure: Change in gambling losses in both the own operator and other operators, in prospective study part Time: 10 daysDescription: Occurrence of self-reported voluntary self-exclusions and help-seeking during the approximate 10-day period after the intervention in the prospective study part (self-reported in survey sent on first business day 10 days after the intervention)
Measure: Occurrence of any self-limiting intervention after the intervention in prospective study part Time: 10 daysDescription: Gambler's self-reported satisfaction (overall) with the call, as responded by telephone to a direct question from the caller, in the retrospective study part
Measure: Gambler's immediate perception of the call Time: 0 daysDescription: Gambler's attitudes to positive and negative effects of the call (feelings of care from the operator and feelings or being annoyed by the call), in the prospective study part (survey sent on first business day 10 days after the intervention)
Measure: Gambler's perception of the intervention Time: 10 daysDescription: Gambler's attitudes to the call with respect to subjective effects on gambling (increasing/decreasing) and help-seeking, in the prospective study part.(survey sent on first business day 10 days after the intervention)
Measure: Gambler's perception of the intervention's effects on gambling Time: 10 daysAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on December 13, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports